scispace - formally typeset
A

Aidong Zhou

Researcher at University of Texas MD Anderson Cancer Center

Publications -  26
Citations -  2174

Aidong Zhou is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Carcinogenesis & Transcription factor. The author has an hindex of 17, co-authored 23 publications receiving 1593 citations. Previous affiliations of Aidong Zhou include Sun Yat-sen University & Hunan Normal University.

Papers
More filters
Journal ArticleDOI

m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.

TL;DR: This work uncovers a critical function for ALKBH5 and provides insight into critical roles of m6A methylation in glioblastoma and a long non-coding RNA antisense to FOXM1 (FOXM1-AS) promotes the interaction of AL KBH5 withFOXM1 nascent transcripts.
Journal ArticleDOI

β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway.

TL;DR: A novel β-catenin/LEF1–miR-372&373–DKK1 regulatory feedback loop is demonstrated, which may have a critical role in regulating the activity of Wnt/β- catenin signaling in human cancer cells.
Journal ArticleDOI

Tumour suppressor TRIM33 targets nuclear β-catenin degradation

TL;DR: It is demonstrated that tripartite motif-containing protein 33 (TRIM33), acting as an E3 ubiquitin ligase, reduces the abundance of nuclear β-catenin protein.
Journal ArticleDOI

FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the Expression of DNA-Repair Gene Rad51

TL;DR: Targeting the FoxM1-Rad51 axis may be an effective method to reverse TMZ resistance in recurrent GBM.